Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool, refine the selection of patients at risk, or help to classify undetermined nodules detected on LDCT. We previously showed that circulating tum...
Saved in:
| Published in: | The lancet respiratory medicine Vol. 8; no. 7; p. 709 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
01.07.2020
|
| ISSN: | 2213-2619, 2213-2619 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!